These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 22503413)

  • 1. Etiology of ovarian hyperstimulation syndrome.
    Orvieto R
    Fertil Steril; 2012 Jun; 97(6):e27; author reply e28. PubMed ID: 22503413
    [No Abstract]   [Full Text] [Related]  

  • 2. Etiology of OHSS and use of dopamine agonists.
    Soares SR
    Fertil Steril; 2012 Mar; 97(3):517-22. PubMed ID: 22265002
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Elimination of ovarian hyperstimulation syndrome.
    Orvieto R
    Fertil Steril; 2012 Jun; 97(6):e29; author reply e30-1. PubMed ID: 22503420
    [No Abstract]   [Full Text] [Related]  

  • 4. [Use of cabergoline for prevention of ovarian hyperstimulation syndrome in assisted reproductive technologies].
    Kozovski G; Angelova M; Kacarova P
    Akush Ginekol (Sofiia); 2014; 53(5):34-5. PubMed ID: 25558669
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ovarian hyperstimulation syndrome: a preventable syndrome?
    Rosenwaks Z; Benadiva C
    Semin Reprod Med; 2010 Nov; 28(6):437-9. PubMed ID: 21082500
    [No Abstract]   [Full Text] [Related]  

  • 6. Do dopamine agonists prevent or reduce the severity of ovarian hyperstimulation syndrome in women undergoing assisted reproduction? A systematic review and meta-analysis.
    Baumgarten M; Polanski L; Campbell B; Raine-Fenning N
    Hum Fertil (Camb); 2013 Sep; 16(3):168-74. PubMed ID: 24047196
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ovarian hyperstimulation: past, present, and future.
    Feinberg EC
    Fertil Steril; 2016 Nov; 106(6):1330. PubMed ID: 27678039
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prevention and treatment of moderate and severe ovarian hyperstimulation syndrome: a guideline.
    ;
    Fertil Steril; 2016 Dec; 106(7):1634-1647. PubMed ID: 27678032
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cabergoline as treatment of ovarian hyperstimulation syndrome: a review.
    Kalampokas T; Creatsas G; Kalampokas E
    Gynecol Endocrinol; 2013 Feb; 29(2):98-100. PubMed ID: 23110560
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prevention of ovarian hyperstimulation syndrome.
    Wiwanitkit V
    Fertil Steril; 2011 Jun; 95(8):e65; author reply e66. PubMed ID: 21530962
    [No Abstract]   [Full Text] [Related]  

  • 11. GnRH agonist triggering in high-risk patients.
    Gurbuz AS; Deveer R; Kuçuk M
    Hum Reprod; 2014 Jul; 29(7):1598. PubMed ID: 24781424
    [No Abstract]   [Full Text] [Related]  

  • 12. Reply: GnRH agonist triggering in high-risk patients.
    Iliodromiti S; Nelson SM
    Hum Reprod; 2014 Jul; 29(7):1598-9. PubMed ID: 24781423
    [No Abstract]   [Full Text] [Related]  

  • 13. Ovarian explosion following ovarian stimulation.
    Taheripanah R; Taslimi S; Karimzadeh MA; Aflatoonian A; Zekavat H
    Acta Obstet Gynecol Scand; 2011 Jul; 90(7):808. PubMed ID: 21488842
    [No Abstract]   [Full Text] [Related]  

  • 14. Dopamine agonist bromocriptine for the prevention of ovarian hyperstimulation syndrome.
    Spitzer D; Wogatzky J; Murtinger M; Zech MH; Haidbauer R; Zech NH
    Fertil Steril; 2011 Jun; 95(8):2742-4.e1. PubMed ID: 21411081
    [TBL] [Abstract][Full Text] [Related]  

  • 15. GnRHa trigger and modified luteal support with one bolus of hCG should be used with caution in extreme responder patients.
    Humaidan P; Thomsen LH; Alsbjerg B
    Hum Reprod; 2013 Sep; 28(9):2593-4. PubMed ID: 23842562
    [No Abstract]   [Full Text] [Related]  

  • 16. Agonist trigger: what is the best approach? Agonist trigger and low dose hCG.
    Humaidan P
    Fertil Steril; 2012 Mar; 97(3):529-30. PubMed ID: 22154368
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reply: GnRHa trigger and modified luteal support with one bolus of hCG should be used with caution in extreme responder patients.
    Ata B; Seyhan A; Polat M; Son WY; Yarali H; Dahan M
    Hum Reprod; 2013 Sep; 28(9):2594-5. PubMed ID: 23842563
    [No Abstract]   [Full Text] [Related]  

  • 18. Agonist trigger: what is the best approach? Agonist trigger with vitrification of oocytes or embryos.
    Garcia-Velasco JA
    Fertil Steril; 2012 Mar; 97(3):527-8. PubMed ID: 22222191
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dopamine agonists in prevention of ovarian hyperstimulation syndrome.
    Kasum M; Vrčić H; Stanić P; Ježek D; Orešković S; Beketić-Orešković L; Pekez M
    Gynecol Endocrinol; 2014; 30(12):845-9. PubMed ID: 25093428
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mild/minimal stimulation for in vitro fertilization: an old idea that needs to be revisited.
    Zarek SM; Muasher SJ
    Fertil Steril; 2011 Jun; 95(8):2449-55. PubMed ID: 21550037
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.